SEC Filing Details

Document Details

Form
Filing Date
May 8, 2009
Document Date
Mar 31, 2009
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline